Claims for Patent: 10,016,415

Summary for Patent: 10,016,415

Title:	Aripiprazole prodrug compositions
Abstract:	Described is a composition comprising (a) a population of particles of an aripiprazole prodrug having a volume based particle size (Dv50) of less than 1000 nm and (b) at least one surface stabilizer comprising an adsorbed component which is adsorbed on the surface of the aripiprazole prodrug particles and a free component available for solubilization of the aripiprazole prodrug. The surface stabilizer to prodrug ratio provides the optimal quantity of free surface stabilizer for the purposes of producing a lead-in formulation. Also described are methods of treatment using the aforementioned composition.
Inventor(s):	Cresswell; Philip (Athlone, IE), Paquette; Sara Montminy (Hudson, MA), Hickey; Magali (Westwood, MA), Perkin; Kristopher (Athlone, IE), Smith; Greg (Norton, MA), Liversidge; Elaine (Charlestown, MA), Steinberg; Brian (Arlington, MA), Manser; David (Keenagh, IE), Turncliff; Ryan (Ashland, MA), Palmieri, Jr.; Michael (Hopkinton, MA), Zeidan; Tarek (Waltham, MA), Cash; Ethan P. (Sudbury, MA), Hard; Marjie L. (Lexington, MA)
Assignee:	ALKERMES PHARMA IRELAND LIMITED (Dublin, IE)
Application Number:	14/828,229
Patent Claims:	1. A composition consisting of polysorbate 20 and a population of particles of the formula: ##STR00005## having a volume based particle distribution size (Dv50) between about 350 nm and about 175 nm as determined by light scattering techniques, wherein the ratio of said particles to polysorbate 20 is 17:1. 2. A composition consisting of polysorbate 20, a chelating agent, a tonicity agent, an aqueous buffer, and a population of particles of the formula: ##STR00006## having a volume based particle distribution size (Dv50) between about 350 nm and about 175 nm as determined by light scattering techniques, wherein the ratio of the particles to polysorbate 20 is 17:1. 3. The composition of claim 2, wherein the chelating agent is sodium citrate. 4. The composition of claim 2, wherein the tonicity agent is sodium chloride. 5. A composition consisting of polysorbate 20, sodium citrate, sodium chloride, an aqueous buffer, and a population of particles of the formula: ##STR00007## having a volume based particle distribution size (Dv50) between about 350 nm and about 175 nm as determined by light scattering techniques, wherein the ratio of the particles to polysorbate 20 is 17:1. 6. A composition consisting of: (a) about 26 weight percent of a compound of the following formula: ##STR00008## (b) 1.53 weight percent polysorbate 20; (c) 0.76 weight percent sodium citrate; (d) 0.31 weight percent sodium chloride; and (e) an aqueous buffer, wherein the compound is provided as a population of particles having a volume based particle distribution size (Dv50) between about 350 nm and about 175 nm as determined by light scattering techniques. 7. The composition of claim 6, wherein the ratio of the particles to polysorbate 20 is 17:1. 8. The composition of claim 2, wherein the composition is an aqueous dispersion.